Last updated: March 4, 2024
Sponsor: University of Oklahoma
Overall Status: Completed
Phase
N/A
Condition
Arrhythmia
Circulation Disorders
Treatment
Kardia 12L
Clinical Study ID
NCT05053243
13692
Ages 18-90 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male and female patients 18 years old or older
- Ability to sit for an ECG and AliveCor Kardia 12L and Kardia 6L recordings for 20minutes
Exclusion
Exclusion Criteria:
- Any internal stimulator that would generate electrical interference with the recordingsystem of the AliveCor Kardia 12L or Kardia 6L.
- Open chest wounds or recent (<30 days) surgery to the chest or abdomen.
- Absence of any limb that would require modification of the lead set-up
Study Design
Total Participants: 221
Treatment Group(s): 1
Primary Treatment: Kardia 12L
Phase:
Study Start date:
September 27, 2021
Estimated Completion Date:
May 24, 2023
Connect with a study center
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.